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OBJECTIVES We evaluated the relation between pressure-derived fractional collateral flow (PDCF) and left
ventricular (LV) recovery after reperfused acute myocardial infarction (AMI).
BACKGROUND The functional significance of collateral flow remains uncertain in AMI.
METHODS The PDCF was measured in 70 patients with first AMI (pain onset ,12 h) treated with
primary angioplasty (PA), being determined by simultaneous measurement of mean aorta
pressure (Pa), distal coronary pressure during the balloon occlusion (Poc), and central venous
pressure (CVP): (Poc 2 CVP)/(Pa 2 CVP)*100. Sufficient collateral (group I) was defined
as PDCF index .24% and insufficient collateral (group II) as PDCF index ,24%.
Echocardiography was performed before, and on day 3, day 7, and day 30 after PA.
Wall-motion recovery index (RI) was obtained by dividing the number of improved
wall-motion segments (.grade 1) at follow-up by the number of abnormal wall-motion
segments within the infarct zone at baseline.
RESULTS Baseline characteristics were similar between both groups. Peak levels of creatine kinase were
lower in group I than in group II (2,600 6 1,900 U/liter vs. 4,100 6 3,000, p , 0.05). At
one month, infarct zone wall-motion score index (1.65 6 0.54 vs. 2.31 6 0.46, p , 0.01) and
LV volume indexes were smaller in group I than in group II, whereas, LV ejection fraction
was higher in group I than in group II (52.8 6 8.3 vs. 45.9 6 9.0, p , 0.01). The PDCF
index was the strongest predictor of RI at one month (r 5 0.61, p , 0.01). Time to
reperfusion was not related to RI at one month. However, it was significantly related to RI
in group II (r 5 20.34, p , 0.05).
CONCLUSIONS The LV recovery after reperfused AMI is primarily determined by PDCF and is less
dependent on time to reperfusion in patients with sufficient collaterals. (J Am Coll Cardiol
2000;35:949–55) © 2000 by the American College of Cardiology
Reperfusion therapy has improved survival in acute myocar-
dial infarction (AMI), and the survival benefit is strongly
dependent on time to reperfusion in thrombolytic trials
(1–4). However, early reperfusion does not guarantee the
recovery in left ventricular (LV) function in clinical trials
(5–8). In addition, recent data suggest that the outcomes of
patients after primary angioplasty may be equally favorable
with early or late treatment, and the duration of coronary
occlusion may be less important for survival after primary
angioplasty than after thrombolytic therapy (9). Therefore,
factors that are independent on time to reperfusion in AMI
deserve to be investigated for the understanding of general
mechanisms of reperfusion benefit.
The coronary collateral circulation is an alternative source
of blood supply to a myocardium jeopardized by abruptly
occluded vessels, preventing myocardial death and favoring
myocardial recovery after reperfusion therapy. However, the
functional significance of collateral circulation in AMI has
been a matter of debate for many years (10–14). The
reasons for this controversy may be related to the difficulty
in assessing the collateral circulation. Coronary angiogra-
phy, the most commonly used technique for studying
collateral circulation, may not be accurate in assessing
collateral circulation because most collaterals are too small
to visualize angiographically (15). Intracoronary pressure
measurement is a new technique to provide accurate and
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quantitative information about the collateral circulation
(16–19), and it can be easily applied during the coronary
intervention.
We therefore hypothesized that 1) pressure-derived frac-
tional collateral flow (PDCF) is a primary determinant of
LV recovery after reperfused AMI, and 2) LV recovery is
relatively independent on time to reperfusion in patients
with sufficient collaterals. To test this hypothesis, we per-
formed a time-course analysis of functional recovery of
regional LV function and its determinants in patients with
first AMI treated with primary angioplasty.
METHODS
Study patients. We prospectively studied 76 patients with
first AMI referred to Asan Medical Center for emergency
primary angioplasty between October 1997 and March 1999
and who met the following criteria: 1) chest pain .30 min
in duration and presentation within 12 h after the onset of
symptoms; 2) ST-segment elevation .0.1 mV in two
contiguous electrocardiographic leads; 3) total occlusion of
the infarct-related artery; and 4) successful primary angio-
plasty (defined as Thrombolysis in Myocardial Infarction
[TIMI] flow grade 3 and residual diameter stenosis ,30%).
Exclusion criteria included the presence of cardiogenic
shock, severe heart failure, previous bypass surgery, atrial
fibrillation, ischemic events during the follow-up, valvular
heart disease, inadequate quality of echocardiographic im-
age, and life-limiting noncardiac disease. Of the 76 patients,
6 were excluded because of inadequate quality of echocar-
diographic images (n 5 1), cardiogenic shock (n 5 1),
severe heart failure (n 5 1), inability to adhere to follow-up
(n 5 1), or reinfarction during the follow-up (n 5 2). Thus,
70 patients were enrolled in the study. All patients received
conventional drug therapy in accordance with standard
clinical practice. Written informed consent was obtained
from all patients, and the study protocol was approved by
our institutional review board.
Measurements of collateral blood flow. Left and right
coronary angiography was performed in all patients, and
then primary angioplasty was performed according to the
study protocol at our institution. A 0.014-in. (0.036 cm)
fiber optic pressure monitoring guide wire (RADI Medical
Systems, Uppsala, Sweden) was set at 0, calibrated, ad-
vanced through the guiding catheter and positioned distal to
the occlusion site to be dilated; balloon inflation at the
occlusion site was performed to measure the collateral flow.
Pressure-derived fractional collateral flow (PDCF) was
determined by simultaneous measurement of aortic pressure
(Pao, mm Hg, obtained from the guiding catheter), the
distal coronary pressure during the balloon occlusion
(Pocc, mm Hg), and central venous pressure (CVP, mm Hg):
PDCF index 5 (Pocc 2 CVP)/(Pao 2 CVP)*100. Angio-
graphic collateral vessels (0 to 3) were graded according to
Rentrop’s classification (20).
Two-dimensional echocardiography. All patients under-
went complete echocardiographic examination with HP
2500 (Hewlett-Packard, Andover, Massachusetts) before
primary angioplasty, and on day 3, day 7, and day 30 after
primary angioplasty. Images were recorded on videotape by
a S-VHS cassette recorder for analysis.
Echocardiogram analysis and definitions. Two investiga-
tors unaware of clinical, collateral and angiographic data
analyzed the echocardiograms, and discrepancies were re-
solved by consensus. Echocardiographic images were trans-
ferred to the hard disk of a TomTec Imaging System
(TomTec, Unterschleissheim, Germany) to obtain quanti-
tative data. The LV end-systolic and end-diastolic volumes
were calculated by computer software according to a mod-
ified Simpson’s rule. Three measurements of the technically
best cardiac cycles, avoiding postectopic beats, were taken
from each examination, and the average volumes were
obtained. The volume indexes were obtained by dividing the
volume by the body surface area at each time point. The LV
ejection fraction was calculated as stroke volume/end-
diastolic volume.
Regional wall motion was assessed according to a 16-
segment model. For each segment, wall motion was scored
as 1 (normal), 2 (hypokinetic), 3 (akinetic) or 4 (dyskinetic).
In evaluating regional wall-motion abnormality, attention
was paid to the systolic thickening in the central portion of
each segment. In each patient, both global and infarct-zone
wall-motion score indexes were derived. Wall-motion re-
covery index was defined as improved wall motion at
follow-up compared with the baseline study, being obtained
by dividing the number of improved wall-motion segment
(a reduction in segmental score of at least one grade) at
follow-up by the number of abnormal wall-motion seg-
ments within the infarct zone at baseline.
Two experienced angiographers unaware of the study
purpose analyzed the infarct-related artery using an on-line
quantitative coronary angiography system (ANCOR V2.0,
Siemens, Germany). Contrast flow through the epicardial
vessel was graded using the standard TIMI flow grade of 0
to 3 (21).
Sufficient collateral was defined as PDCF index .24%, as
described previously (16). Time to reperfusion was mea-
sured as the time from the onset of symptoms until coronary
reperfusion was established with balloon inflation. The
impact of preinfarction angina on wall-motion recovery was
evaluated based on the presence or absence of antecedent
angina within 24 h before the onset of AMI (22). Cardiac
enzyme (creatine kinase, creatine kinase-MB) was serially
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
LV 5 left ventricle/ventricular
PDCF 5 pressure-derived fractional collateral flow
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measured at 4-h intervals up to 24 h and later at 8-h
intervals up to 72 h after intervention, and the maximum
level was used as an enzymatic marker of infarct size.
Interobserver and intraobserver variability. Interobserver
reproducibility was checked by selecting 10 random study
echocardiograms for reinterpretation by a second investiga-
tor. Intraobserver variability was also assessed by having the
initial investigator reanalyze 10 randomly selected echocar-
diograms on a different occasion. The agreement was good
for measurements of wall-motion score index (interobserver
variability: r 5 0.93, p , 0.01; intraobserver variability: r 5
0.95, p , 0.01). Interobserver and intraobserver variability
values in the evaluation of end-systolic and end-diastolic
volumes were ,5%.
Statistical analysis. Statistical analysis was performed us-
ing SPSS 7.5 for Windows. Data were expressed as mean 6
SD for continuous variables and frequencies for the cate-
gorical variables. Continuous variables were compared by
unpaired Student t test, and categorical variables by chi-
square test. The comparisons between the two patient
groups over time were done with a two-way repeated-
measures analysis of variance (ANOVA). Linear regression
analysis was performed on all variables to identify determi-
nants of wall-motion recovery index, and variables found to
be p , 0.1 by univariate analysis were entered into a
stepwise multiple linear regression analysis to determine
their independent relationship to wall-motion recovery
index. A p value ,0.05 was considered statistically signifi-
cant.
RESULTS
Baseline characteristics. The study population was di-
vided into two groups according to the PDCF index: group
I (PDCF index .24%, n 5 30) and group II (PDCF index
#24%, n 5 40). As shown in Table 1 and Table 2, there
were no significant differences between the two groups with
respect to age, gender, risk factors, time to reperfusion,
echocardiographic variables, and angiographic characteris-
Table 1. Baseline Clinical Characteristics





Age, yrs 55.1 6 12.4 60.6 6 11.0
Male/female 25/5 31/9
Killip classification 1.37 6 0.49 1.60 6 0.63
Risk factors
Diabetes mellitus 6 (20.0%) 5 (12.5%)
Cholesterol (.200 mg/dl) 10 (33.3%) 10 (25.0%)
Hypertension 6 (20.0%) 12 (30.0%)
Smoking 17 (56.7%) 15 (37.5%)
Time to reperfusion (h) 5.2 6 3.4 4.2 6 2.4
Peak CK, U/liter 2,600 6 1,900 4,100 6 3,000*
Peak time of CK (h) 8.4 6 3.0 10.2 6 13.2
IZ WMSI before reperfusion 2.76 6 0.32 2.78 6 0.21
E peak, cm/s 68.6 6 19.4 66.0 6 19.5
A peak, cm/s 60.3 6 22.0 70.5 6 27.1
Deceleration time, ms 165.0 6 51.2 164.3 6 47.9
Multivessel disease, % 12 (33.3%) 12 (30.0%)
Use of abciximab 4 (13.3%) 5 (12.5%)
CK 5 creatine kinase; PDCF 5 pressure-derived fractional collateral flow; IZ WMSI 5 infarct zone wall-motion score index;
*p , 0.05.








19 (63.3%) 24 (60.0%)
Left circumflex artery 1 (3.3%) 3 (7.5%)
Right coronary artery 10 (33.3%) 13 (32.5%)
Primary angioplasty
Balloon angioplasty 8 (26.7%) 11 (27.5%)
Stent placement 22 (73.3%) 29 (72.5%)
Reference artery size, mm 3.24 6 0.49 3.20 6 0.52
Minimal lumen diameter, mm
Baseline 0 0
Final 2.91 6 0.61 2.91 6 0.50
Diameter stenosis, %
Baseline 100 100
Final 10.3 6 12.2 9.9 6 8.4
Balloon-to-artery ratio 1.1 6 0.1 1.1 6 0.3
Maximum inflation pressure, atm 13.3 6 3.6 14.5 6 2.5
No differences between the two groups.
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tics. However, patients in group II had higher peak levels of
creatine kinase than did those in group I (4,100 6 3,000
U/liter vs. 2,600 6 1,900, respectively, p , 0.05).
Angiographic and pressure measurements of the collat-
eral circulation. Angiographic collateral grade was signif-
icantly related to PDCF index (r 5 0.33, p , 0.05, Fig. 1).
However, a wide range of the PDCF index was observed in
patients with angiographic collaterals , grade 1 (Fig. 1). A
significant correlation was also found between peak levels of
creatine kinase and PDCF index (r 5 20.38, p , 0.01, Fig.
2).
Changes in regional and global LV function. Figure 3
shows a significant progressive improvement in regional
contractile function (wall-motion score index and recovery
index) within the infarct zone in both groups. However,
regional contractile function was more rapidly and greatly
recovered in group I than in group II (p , 0.01 for the
difference in the linear component of the group-by-time
interaction). At baseline, LV ejection fraction (49.5 6 6.6%
vs. 48.4 6 6.6, respectively, p 5 NS), LV end-systolic
volume index (26.7 6 6.9 ml/m2 vs. 26.4 6 9.5, p 5 NS),
and LV end-diastolic volume index (52.8 6 11.2 ml/m2 vs.
51.2 6 13.9, p 5 NS) were similar between the two groups.
At one-month follow-up, LV ejection fraction was signifi-
cantly higher in group I than in group II (52.8 6 8.3 vs.
46.0 6 9.0, respectively, p , 0.01). However, LV end-
systolic volume index (27.4 6 7.2 ml/m2 vs. 35.8 6 13.1,
respectively, p , 0.01) and LV end-diastolic volume index
(58.0 6 10.6 ml/m2 vs. 65.6 6 18.0, respectively, p , 0.05)
were smaller in group I than in group II.
Predictors of wall-motion recovery index at one month.
To evaluate the predictors of infarct zone wall-motion
recovery index at one-month follow-up, clinical, hemody-
namic and angiographic factors were analyzed by regression
analysis (Table 3). Wall-motion recovery index at one
month was significantly associated with PDCF index (r 5
0.61, p , 0.01, Fig. 4A), angiographic collaterals (r 5 0.26,
p , 0.05) and LV ejection fraction before reperfusion (r 5
0.33, p , 0.01). However, the PDCF index was the only
independent predictor of wall-motion recovery index at one
month by multiple regression analysis. Time to reperfusion
or the presence of preinfarction angina was not associated
Figure 1. Relation between angiographic collaterals and pressure-
derived fractional collateral flow (PDCF). Weak correlation is
noted between the two variables.
Figure 2. Inverse correlation between pressure-derived fractional
collateral flow (PDCF) and peak levels of creatine kinase.
Figure 3. Time course of infarct zone wall-motion score index
(WMSI; A) and wall-motion recovery index (B). Infarct zone-wall
motion recovery was more rapid and complete in group I (PDCF
index .24%) than in group II (PDCF index #24%). *p , 0.05
between groups; †p , 0.01 between groups; ‡p , 0.01 within
group vs. day 0. Data are mean 6 SD.
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with wall-motion recovery index at one month (Table 3,
Fig. 4B), whereas in group II time to reperfusion was
significantly related to wall-motion recovery index at one
month (r 5 20.34, p , 0.05, Fig. 4C).
DISCUSSION
The major findings of this study are that 1) PDCF index is
the most powerful predictor of LV recovery after success-
fully reperfused AMI, and 2) time to reperfusion is less
important for recovery of LV function in patients with
sufficient collaterals. These findings may provide a physio-
logic basis for the understanding of the time-“less depen-
dent” beneficial effects of primary angioplasty on mortality
(9). Furthermore, this study demonstrates that the PDCF
index is more accurate than angiographic collaterals in
assessing the functional significance of the collateral circu-
lation in AMI.
Comparison with previous studies. After occlusion of a
major coronary artery, the only blood flow to the ischemic
myocardium arrives via coronary collaterals. In experimental
animals, collateral blood flow is a major determinant of the
extent of necrosis after coronary artery occlusion (23,24).
However, the role of the collateral circulation in humans
remains speculative (10–14). Some studies suggest that
collateral channels do not reduce the infarct size (10–12),
and others indicate that coronary collateral can mitigate the
myocardial necrosis in AMI (13,14). The controversy may
stem from limitation of previous clinical studies, including
use of angiographic collaterals and delay in the assessment
of collaterals after the onset of myocardial infarction. Unfor-
tunately, angiographically visible collaterals represent only a
fraction of the total collateral vessels because collaterals are
angiographically demonstrable only when they reach 100 mm.
Moreover, angiography may not detect most collaterals
situated intramurally, whereas intracoronary pressure mea-
surements provide the opportunity to measure the contri-
bution of total collateral flow in humans (16–19), allowing
quantitative assessment of collateral flow before reperfusion
in AMI. Using this technique, the present study demon-
strates that the PDCF index is a major determinant of LV
recovery after successful primary angioplasty, which may in
part explain the beneficial effects of late reperfusion in AMI.
Furthermore, this study suggests that PDCF measurements
can be used to predict LV recovery in patients undergoing
catheterization for AMI.
Table 3. Predictors of Wall-Motion Recovery Index at
One-Month (Univariate Analysis)
Variables r Value p Value
PDCF index, % 0.61 , 0.01
Angiographic collateral grade 0.26 , 0.05
Time to reperfusion (h) 0.004 NS
Preinfarction angina (,24 h) 0.15 NS
Age 0.17 NS
Mean blood pressure, mm Hg 0.12 NS
Heart rate 0.03 NS
LVEF before reperfusion 0.33 , 0.01
Multivessel disease ($2) 0.04 NS
PDCF 5 pressure-derived fractional collateral flow; LVEF 5 left ventricular ejection
fraction.
Figure 4. Predictors of wall-motion recovery index at 30-day
follow-up. (A) Good positive correlation between wall-motion
recovery index and pressure-derived fractional collateral flow
(PDCF). (B) No correlation between wall-motion recovery index
and time to reperfusion. (C) Inverse correlation between wall-
motion recovery index and time to reperfusion in patients with
insufficient collaterals (group II).
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In patients with angiographically robust collaterals, the
correlation between angiographic collaterals and PDCF
index was quite good, whereas in those with angiographi-
cally less visible collaterals there appears to be substantial
scatter. The discrepancy between the angiographic collater-
als and PDCF index in the latter patients remains uncertain.
It is known that serotonin causes constriction of coronary
artery vessels .90 mm in diameter, but dilation of arterioles
,90 mm in diameter (25,26). We therefore suppose that
serotonin and thromboxane A2 released by platelet activa-
tion may cause vasoconstriction of the epicardial collateral
vessels, leading to angiographic underestimation of the
collateral circulation in the very early phase of AMI (25–
28). This may be a plausible explanation, but further studies
may be required to ascertain these issues.
Ischemic time and LV function. Time to reperfusion has
been of great interest ever since the advent of thrombolytic
therapy. In experimental models, myocardial necrosis is
time dependent, progressing a wave front from subendocar-
dium to subepicardium, with complete necrosis after 6 h
(29). These findings underlie the current clinical use of
thrombolytic therapy. The time-related benefits of throm-
bolysis are well demonstrated by the randomized trials,
showing a good correlation between reperfusion time and
mortality (30). However, the reperfusion benefit does not
appear to be translated into an LV function. This discrep-
ancy between the impressive reduction in mortality and the
relative lack of effect on LV function has been a source of
debate (31). This paradox questions the traditionally ac-
cepted relationship among coronary artery patency, myocar-
dial salvage, and LV function, leading to the hypothesis that
patency is not equal to reperfusion (“illusion of reperfusion”)
(32).
Primary angioplasty in AMI has been shown to result in
lower rates of mortality, reinfarction, and stroke compared
with thrombolysis, thus enhancing the quality of reperfusion
therapy (33–35). Interestingly, recent data from the PAMI
trial (9) revealed that mortality and reinfarction are relatively
constant with increasing time to reperfusion, suggesting
that factors that are independent on time to reperfusion may
be responsible for much of the survival benefit with primary
angioplasty. In fact, a substantial number of patients with
early reperfusion do not show reduction of the infarct size in
the chronic phase. The results of the present study may in
part account for a wide rage of clinical outcomes in patients
with reperfused AMI.
The effect of preinfarction angina on LV function in
AMI remains controversial (36–39). Previous studies sug-
gested that preinfarction angina was beneficial for event rate
when the time between onset of angina and AMI was
within 24 h. In our study, angina ,24 h before AMI did not
have a favorable effect on LV function (39). This does not
necessarily mean that preinfarction angina is not effective in
reducing infarct size. However, our results suggest that
preinfarction angina seems to be of minor importance in
limiting infarct size, as compared with collateral circulation.
Study limitations. Several potential limitations need to be
addressed. First, 30-day follow-up angiogram was not
obtained in this study, and therefore the possibility of silent
reocclusion could not be excluded. Second, myocardial
contrast echocardiography was not performed in this study,
which is also an excellent tool to assess the collateral
circulation. Therefore, we could not evaluate the relation-
ship between the PDCF index and collaterals by myocardial
contrast echocardiography. Third, our findings are derived
from a select population of AMI patients who were suc-
cessfully treated with primary angioplasty. In addition,
patients with hemodynamic instability were excluded from
the study because the PDCF index is difficult to obtain in
this situation. Hence, our results may not be generalized to
all patients receiving reperfusion therapy. Nevertheless, this
study confirms the importance of collateral blood flow in
AMI, and it reveals that time dependency in AMI may be
changed by adequacy of collateral blood flow.
Conclusions. On the basis of our findings, we conclude
that collateral blood flow, not detectable by angiography,
may preserve the myocardium in acute phase of AMI, thus
contributing to improvement in LV function after successful
primary angioplasty.
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